SynVaccine
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
27 Habarzel St, Tel Aviv, Tel Aviv, 6971...Phone Number
+972 37684938Website
www.synvaccine.comRevenue
<$5 MillionIndustry
About SynVaccine
Is SynVaccine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if SynVaccine had a recent Job posting/layoffs
Earning: See what the market has to say on SynVaccine recently announced quarterly report
Product Launch: Get notified when SynVaccine launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once SynVaccine has new funding data
SynVaccine, which may be a good buyer, showed buying intent in Masked Content Topic
Check if SynVaccine has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if SynVaccine is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at SynVaccine
Recommended Actions
Find VP level buyers at SynVaccine
Find 2 more new buyers
Company Profile Activity
Activity Insights
SynVaccine is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SynVaccine is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SynVaccine.
SynVaccine financials insights
Gather financial insights about SynVaccine, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$1.7M
SynVaccine Tech Stack
A closer look at the technologies used by SynVaccine
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SynVaccine
SynVaccine is a computational design company specializing in viral engineering for medical applications, including vaccines, oncolytic viruses, phage therapy, and gene therapy. The company utilizes its proprietary platform, SynRAD, to revolutionize gene therapy, cancer immunotherapy, and the treatment of infectious diseases through rational design... Read More